Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    3.50 (1.43%)
Bid:
249.00
Ask:
251.00
Spread: 2.00 (0.803%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Director/PDMR Shareholding

7 May 2026 16:36

RNS Number : 4879D
MJ Gleeson PLC
07 May 2026
 

7 May 2026

 

 

MJ Gleeson Plc

("the Company")

 

Notification of Transaction by Directors/PDMRs

 

The Company was notified on 6 May 2026 that the Directors and Persons Discharging Management Responsibilities ("PDMR") listed below acquired Ordinary shares in the Company in London on 5 May 2026 at a purchase price of £2.43 per Ordinary Share through a Profit Sharing Employee Share Ownership Scheme (the "Scheme") which has been approved by HMRC.

 

This information set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

1.

Details of the issuer or emission allowance market participant

a)

Full name of the entity

MJ Gleeson Plc

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

2.

Reasons for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the person discharging managerial responsibilities (PDMR) / person closely associated with a PDMR (PCA)

a)

Is this a PDMR or PCA submission?

PDMR

b

First Name

Stefan

b)

Last Name

Allanson

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of instrument

 

Share

b)

Identification Code

GB00BRKD9Z53

c)

Nature of the transaction

Acquisition of Ordinary Shares of £0.02 each through the Scheme

d)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.43 per share

82 shares

Note: this was a single transaction.

e)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction.

f)

Date of the transaction

 

2026-05-05

 

g)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

 

1.

Details of the issuer or emission allowance market participant

a)

Full name of the entity

MJ Gleeson Plc

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

2.

Reasons for the notification

a)

Position / status

Company Secretary

b)

Initial notification / amendment

Initial notification

3.

Details of the person discharging managerial responsibilities (PDMR) / person closely associated with a PDMR (PCA)

a)

Is this a PDMR or PCA submission?

PDMR

b

First Name

Leanne

b)

Last Name

Johnson

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of instrument

 

Share

b)

Identification Code

GB00BRKD9Z53

c)

Nature of the transaction

Acquisition of Ordinary Shares of £0.02 each through the Scheme

d)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.43 per share

82 shares

Note: this was a single transaction.

e)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction.

f)

Date of the transaction

 

2026-05-05

 

g)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

 

1.

Details of the issuer or emission allowance market participant

a)

Full name of the entity

MJ Gleeson Plc

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

2.

Reasons for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the person discharging managerial responsibilities (PDMR) / person closely associated with a PDMR (PCA)

a)

Is this a PDMR or PCA submission?

PDMR

b

First Name

Graham

b)

Last Name

Prothero

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of instrument

 

Share

b)

Identification Code

GB00BRKD9Z53

c)

Nature of the transaction

Acquisition of Ordinary Shares of £0.02 each through the Scheme

d)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.43 per share

81 shares

Note: this was a single transaction.

e)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction.

f)

Date of the transaction

 

2026-05-05

 

g)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

 

1.

Details of the issuer or emission allowance market participant

a)

Full name of the entity

MJ Gleeson Plc

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

2.

Reasons for the notification

a)

Position / status

Chief Operating Officer (Gleeson Homes)

b)

Initial notification / amendment

Initial notification

3.

Details of the person discharging managerial responsibilities (PDMR) / person closely associated with a PDMR (PCA)

a)

Is this a PDMR or PCA submission?

PDMR

b

First Name

Simon

b)

Last Name

Topliss

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of instrument

 

Share

b)

Identification Code

GB00BRKD9Z53

c)

Nature of the transaction

Acquisition of Ordinary Shares of £0.02 each through the Scheme

d)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.43 per share

82 shares

Note: this was a single transaction.

e)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction.

f)

Date of the transaction

 

2026-05-05

 

g)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

Enquiries:

 

Leanne Johnson

Company Secretary

MJ Gleeson plc Tel: 01142 612900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHARMATMTJMBFF
Date   Source Headline
30th Nov 20237:00 amRNSTotal Voting Rights
27th Nov 20234:29 pmRNSDirector/PDMR Shareholding
16th Nov 20231:33 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
8th Nov 20233:29 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
24th Oct 20234:17 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:56 pmRNSExercise of Options & Director/ PDMR Dealing
17th Oct 20237:00 amRNSNotice of AGM
6th Oct 20232:37 pmRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSTotal Voting Rights
27th Sep 20234:17 pmRNSExercise of Options & PDMR Dealing
26th Sep 20234:38 pmRNSDirector/PDMR Shareholding
15th Sep 20233:54 pmRNSDirector/PDMR Shareholding
15th Sep 202310:35 amRNSDirector/PDMR Shareholding
14th Sep 20234:41 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
7th Sep 202312:20 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSTotal Voting Rights
8th Aug 20234:55 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSTotal Voting Rights
7th Jul 20233:48 pmRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSTrading Update and Capital Markets Day
30th Jun 20237:00 amRNSSale of portfolio of homes to Carlyle
30th Jun 20237:00 amRNSTotal Voting Rights
8th Jun 20232:23 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
15th May 20233:30 pmRNSHolding(s) in Company
10th May 20231:56 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate
30th Dec 20227:00 amRNSTotal Voting Rights
15th Dec 202211:06 amRNSDirectorate External Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.